Skip to main content

NIH Grants for Pharmacogenomics Research: Jul 21, 2005

Premium
NIH Grants for Pharmacogenomics Research
FY'05 June 13 — July 17
City, State, or Country Name
Organization Name
Principal Investigator
Award
Title
Alabama
Birmingham
University of Alabama at Birmingham Hughes,
Laura B
$107,043
Pharmacogenetics of Methotrexate in Rheumatoid Arthritis
California
San Francisco
University of California, San Francisco Benowitz,
Neal L
$188,512
Clinical Pharmacology, Drug Action, & Pharmacogenetics
San Francisco University of California, San Francisco Giacomini,
Kathleen M
$2,584,827
Pharmacogenetics of Membrane Transporters
San Francisco University of California, San Francisco Szoka,
Francis C
$232,125
Pharmaceutical Sciences and Pharmacogenomics
San Francisco University of California, San Francisco Hauser,
Stephen L
$2,717,681
A Haplotype Map for Multiple Sclerosis
La Jolla University of California, San Diego Nigam,
Sanjay K
$294,525
SNPs in Handling of Small Pox Antivirals & Other Drugs
Los Angeles University of California, Los Angeles Nelson,
Stanley F
$872,727
UCLA NINDS/NIMH Microarray Center
San Diego Veterans Medical Research Foundation, San Diego Patel,
Piyush M
$363,216
Microarray analysis of neuronal ischemic preconditioning
Colorado
Aurora
University of Colorado Denver/HSC Aurora Zahniser,
Nancy R
$112,440
Behavioral Pharmacogenetics of Drug & Alcohol Abuse
Connecticut
New Haven
Yale University Mane,
Shrikant M
$1,245,816
Yale Microarray Center for Research on the Nervous Syste
Florida
Tampa
H. Lee Moffitt Cancer Center and Research Institute Lancaster,
Johnathan M
$81,500
Plasma Microarray Analysis and Ovarian Cancer Biomarkers
Illinois
Chicago
University of Chicago Ratain,
Mark J
$3,000,870
Pharmacogenetics of Anticancer Agents Research Group
Kentucky
Louisville
University of Louisville Hein,
David W
$398,047
Pharmacogenetics of drug and carcinogen metabolism
Maryland
Baltimore
Johns Hopkins University Hidalgo,
Manuel
$297,040
Pharmacogenomics of Erlotinib
Massachussetts
Cambridge
Harvard University Liu, Jun
$326,000
Computational Haplotype Analysis for SNPs
Boston Massachusetts General Hospital Seed, Brian
$785,548
Shared Microarray Facility
Boston Massachusetts General Hospital Thadhani,
Ravi I
$137,500
Antibody Microarray Predicting Pima Diabetic Nephropathy
Minnesota
Rochester
Mayo Clinic College of Medicine, Rochester Weinshilboum, Richard M
$2,460,531
Pharmacogenetics of Phase II Drug Metabolizing Enzymes
Rochester Mayo Clinic College of Medicine, Rochester Turner,
Stephen T
$859,934
Anthipertensive PharmacoGenomics
Minneapolis University of Minnesota, Twin Cities Tracy,
Timothy S
$241,600
Pharmacogenetics and Drug Interactions
Missouri
St. Louis
Washington University Mcleod, Howard L
$157,638
Ovarian Cancer Pharmacogenetics
North Carolina
Durham
Duke University Allen,
Andrew S
$142,101
Advanced Haplotype Analyses in Coronary Artery Disease
Durham Duke University Nevins,
Joseph R
$728,625
Functional Microarray Facility
Pennsylvania
Philadelphia
University of Pennsylvania Lerman,
Caryn E
$390,071
Pharmacogenetic Investigation of Naltrexone
Pittsburgh University of Pittsburgh Li, Song
$367,360
Pharmacogenetic Therapy of Pulmonary Hypertension
Texas
San Antonio
University of Texas Health Science Center San Antonio Suh, Yousin
$288,096
Association Analysis of SNPs in Longevity Assurance Gen
Utah
Salt Lake City
LDS Hospital Anderson,
Jeffrey L
$575,237
Risk Burden of Lipoprotein Metabolic Gene Haplotypes
Washington
Seattle
Fred Hutchinson Cancer Research Center Zhao,
Lue Ping
$389,250
Methods for Correlating SNP Haplotypes with Cancer
*SOURCE: US National Institutes of Health

Filed under

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.